⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for fgfr3 receptor

Every month we try and update this database with for fgfr3 receptor cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
A Study of [225Ac]-FPI-1966 in Participants With Advanced Solid TumoursNCT05363605
Advanced Solid ...
Head and Neck S...
Bladder Carcino...
Susceptible FGF...
FGFR3
FGFR3 Overexpre...
FGFR3 Receptor
FGFR3 Protein O...
Ovarian Cancer
Colorectal Canc...
Breast Cancer
Liver Cancer
Lung Cancer
Gastric Cancer
[225Ac]-FPI-196...
[111In]-FPI-196...
vofatamab
18 Years - Fusion Pharmaceuticals Inc.
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: